Trial Profile
A prospective trial evaluating the efficacy and safety of panitumumab in frail elderly patients with metastatic RAS and BRAF wild-type colorectal cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 15 Oct 2016
Price :
$35
*
At a glance
- Drugs Panitumumab (Primary)
- Indications Colorectal cancer
- Focus Adverse reactions; Therapeutic Use
- 15 Oct 2016 New trial record